Literature DB >> 17336101

Definition of a direct extracellular interaction between Met and E-cadherin.

Galina Reshetnikova1, Sergei Troyanovsky, David L Rimm.   

Abstract

High levels of the Met tyrosine kinase receptor expression are associated with metastatic disease. Met activation by hepatocyte growth factor (HGF) is associated with decreased E-cadherin-dependent cell-cell contacts. The molecular mechanism underlying this process remains unclear. To better understand the relationship between E-cadherin and Met, we assessed Met localization in cells which form mature E-cadherin-dependent adhesion HT-29 and cells which have lost E-cadherin expression BT-549. Met colocalized with E-cadherin at the site of cell-cell adhesion in HT-29 cells, but Met was distributed in an intracellular compartment in BT-549 cells. Forced expression of E-cadherin in BT-549 cells recruited Met to the membrane. Cross-linking studies suggested that Met and E-cadherin interact in the extracellular domain in HT-29 cells. This is the first evidence of a physical interaction between Met and E-cadherin. We suggest that this receptor/cadherin pairing may be a mechanism for cellular presentation of receptors in a manner that localizes them optimally for interaction with ligand.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17336101     DOI: 10.1016/j.cellbi.2007.01.022

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  14 in total

1.  Mapping transmembrane binding partners for E-cadherin ectodomains.

Authors:  Omer Shafraz; Bin Xie; Soichiro Yamada; Sanjeevi Sivasankar
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-23       Impact factor: 11.205

Review 2.  Roles of miRNA and lncRNA in triple-negative breast cancer.

Authors:  Juan Xu; Kang-Jing Wu; Qiao-Jun Jia; Xian-Feng Ding
Journal:  J Zhejiang Univ Sci B       Date:  2020 Sept.       Impact factor: 3.066

3.  E-cadherin surface levels in epithelial growth factor-stimulated cells depend on adherens junction protein shrew-1.

Authors:  Julia Christina Gross; Alexander Schreiner; Knut Engels; Anna Starzinski-Powitz
Journal:  Mol Biol Cell       Date:  2009-06-10       Impact factor: 4.138

Review 4.  MET: a critical player in tumorigenesis and therapeutic target.

Authors:  Carrie R Graveel; David Tolbert; George F Vande Woude
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-07-01       Impact factor: 10.005

5.  Combined γ-tocotrienol and Met inhibitor treatment suppresses mammary cancer cell proliferation, epithelial-to-mesenchymal transition and migration.

Authors:  N M Ayoub; M R Akl; P W Sylvester
Journal:  Cell Prolif       Date:  2013-08-23       Impact factor: 6.831

6.  Olive phenolics as c-Met inhibitors: (-)-Oleocanthal attenuates cell proliferation, invasiveness, and tumor growth in breast cancer models.

Authors:  Mohamed R Akl; Nehad M Ayoub; Mohamed M Mohyeldin; Belnaser A Busnena; Ahmed I Foudah; Yong-Yu Liu; Khalid A Ei Sayed
Journal:  PLoS One       Date:  2014-05-21       Impact factor: 3.240

7.  Met kinetic signature derived from the response to HGF/SF in a cellular model predicts breast cancer patient survival.

Authors:  Gideon Y Stein; Nir Yosef; Hadar Reichman; Judith Horev; Adi Laser-Azogui; Angelique Berens; James Resau; Eytan Ruppin; Roded Sharan; Ilan Tsarfaty
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

8.  Inter-cellular adhesion disruption and the RAS/RAF and beta-catenin signalling in lung cancer progression.

Authors:  Rudolf Götz
Journal:  Cancer Cell Int       Date:  2008-05-20       Impact factor: 5.722

9.  Markers of epithelial to mesenchymal transition in association with survival in head and neck squamous cell carcinoma (HNSCC).

Authors:  Eirini Pectasides; Theodoros Rampias; Clarence Sasaki; Christos Perisanidis; Vassilis Kouloulias; Barbara Burtness; Thomas Zaramboukas; David Rimm; George Fountzilas; Amanda Psyrri
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

10.  A novel class I HDAC inhibitor, MPT0G030, induces cell apoptosis and differentiation in human colorectal cancer cells via HDAC1/PKCδ and E-cadherin.

Authors:  Li-Ting Wang; Jing-Ping Liou; Yu-Hsuan Li; Yi-Min Liu; Shiow-Lin Pan; Che-Ming Teng
Journal:  Oncotarget       Date:  2014-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.